74346-19-3

Basic information

• Product Name: 4-bromo-2,6-dimethylbenzoic acid
• Synonyms: 4-bromo-2,6-dimethylbenzoic acid;Benzoic acid, 4-broMo-2,6-diMethyl-
• CAS NO: 74346-19-3
• Molecular Formula: C₉H₉BrO₂
• Molecular Weight: 229.07
• Mol File: 74346-19-3.mol
• Article Data: 9

Chemical Properties

• Melting Point: 197-198 °C
• Boiling Point: 321.106 °C at 760 mmHg
• Flash Point: 148 °C
• Appearance: /
• Density: 1.52 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.585
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 3.29±0.37(Predicted)
• CAS DataBase Reference: 4-bromo-2,6-dimethylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2,6-dimethylbenzoic acid(74346-19-3)
• EPA Substance Registry System: 4-bromo-2,6-dimethylbenzoic acid(74346-19-3)

Safety Data

• Hazardous Substances Data: 74346-19-3(Hazardous Substances Data)

Usage

Chemical Properties

off-white powder

InChI:InChI=1/C9H9BrO2/c1-5-3-7(10)4-6(2)8(5)9(11)12/h3-4H,1-2H3,(H,11,12)

Upstream product

• 110-05-4 di-tert-butyl peroxide 
• 68837-59-2 4-bromo-2-methylbenzoic acid 
• 124-38-9 carbon dioxide 
• 206559-43-5 5-bromo-2-iodo-1,3-dimethyl-benzene 
• 87-62-7 2,6-dimethylaniline 
• 90841-46-6 methyl 4-bromo-2,6-dimethylbenzoate 
• 5757-66-4 4-bromo-2,6-dimethylbenzonitrile 
• 920-39-8 isopropylmagnesium bromide 
• 132949-41-8 4-Bromo-2,6-dimethylbenzamide 
• 24596-19-8 4-bromo-2,6-dimethylphenylamine 

Downstream Products

• 890839-23-3 2,6-dimethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzoic acid 
• 877149-62-7 7-methyl-1-oxo-2-[4-(trifluoromethoxy)benzyl]-2,3-dihydro-1H-isoindole-5-carbonitrile 
• 877149-74-1 7-methyl-1-oxo-2-[4-(trifluoromethoxy)benzyl]-2,3-dihydro-1H-isoindole-5-carboxylic acid 
• 877149-28-5 5-bromo-7-methyl-2-[4-(trifluoromethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one 
• 927210-23-9 tert-butyl 4-[(5-{7-methyl-1-oxo-2-[4-(trifluoromethoxy)benzyl]-2,3-dihydro-1H-isoindol-5-yl}-1,2,4-oxadiazol-3-yl)methyl]piperazine-1-carboxylate 
• 1314217-78-1 4-bromo-2-(hydroxymethyl)-6-methyl-N-[4-(trifluoromethoxy)benzyl]benzamide 
• 1314217-69-0 7-methyl-5-[(3-piperazin-1-ylmethyl)-1,2,4-oxadiazol-5-yl]-2-[4-(trifluoromethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one methanesulphonate 
• 306296-76-4 2,6-dimethyl-4-formyl benzoic acid 
• 877149-15-0 methyl 4-bromo-2-(bromomethyl)-6-methylbenzoate 
• 1609401-43-5 4-bromo-2,6-dimethyl-N-(quinolin-8-yl)benzamide 
• 1154060-59-9 4-bromo-2,6-dimethyl-N-(2-sulfamoylphenylsulfonyl)benzamide 

Relevant articles and documents

Preparation method for o-tolylacetic acid aryl formic acid derivative

The invention discloses a preparation method for an o-tolylacetic acid aryl formic acid derivative. According to the method, new C-C bonds can be formed, the organic o-tolylacetic acid aryl formic acid derivative is obtained, the good functional group tolerance is achieved, and the o-tolylacetic acid aryl formic acid derivative which cannot be easily obtained by adopting other methods can be synthesized; according to the method, adopted raw materials are easy to obtain, the yield is high, the reaction conditions are mild, the substrate range is wide, and after-treatment is simple and green.

BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS

Disclosed are promoieties of the following formula which can be used to form prodrugs of nitrogen-containing or hydroxyl-containing drug or a pharmaceutically active agent: (I) and pharmaceutical compositions comprising the prodrugs.

PROCESS FOR MAKING A METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR - 874

Processes for making 7-methyl-5-(3piperazin-1-ylmethyl-[1,2,4]oxadiazol-5-yl)-2-(4- trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one